SARS-CoV-2 fluorescent tool for drug development; plus Alzheimer's biomarkers, Nature, National Academies and Pylum

BioCentury's roundup of preclinical news

DNA-based tool for developing COVID-19 countermeasures

University of Texas Medical Branch researchers have created a fluorescent SARS-CoV-2 DNA clone as a reporter tool for preclinically assessing COVID-19 vaccines and treatments. Described in Cell Host and Microbe, the reporter is a reverse transcribed SARS-CoV-2

Read the full 422 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE